TY - JOUR AU - Hovstadius, B. PY - 2010 DA - 2010// TI - Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008 JO - BMC Clin Pharmacol VL - 10 UR - https://doi.org/10.1186/1472-6904-10-16 DO - 10.1186/1472-6904-10-16 ID - Hovstadius2010 ER - TY - STD TI - Onder G, et al. Advanced age and medication prescription: More years, less medications? A nationwide report from the Italian medicines agency. J Am Med Director Assoc. 2016;17(2):168-72. ID - ref2 ER - TY - JOUR AU - Flaherty, J. H. PY - 2000 DA - 2000// TI - Polypharmacy and hospitalization among older home care patients JO - J Gerontol A Biol Sci Med Sci VL - 55 UR - https://doi.org/10.1093/gerona/55.10.M554 DO - 10.1093/gerona/55.10.M554 ID - Flaherty2000 ER - TY - JOUR AU - Gregg, D. AU - Goldschmidt-Clermont, P. J. PY - 2003 DA - 2003// TI - Platelets and cardiovascular disease JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000086897.15588.4B DO - 10.1161/01.CIR.0000086897.15588.4B ID - Gregg2003 ER - TY - JOUR AU - Silber, S. PY - 2010 DA - 2010// TI - Evidence-based management of ST-segment elevation myocardial infarction (STEMI): latest guidelines of the European Society of Cardiology (ESC) 2010. [German] Evidenzbasiertes Vorgehen beim ST-Strecken-Hebungsinfarkt (STEMI): Neueste Leitlinien der Europaischen Gesellschaft fur Kardiologie (ESC) 2010 JO - Herz VL - 35 UR - https://doi.org/10.1007/s00059-010-3401-8 DO - 10.1007/s00059-010-3401-8 ID - Silber2010 ER - TY - JOUR AU - Perk, J. PY - 2013 DA - 2013// TI - European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) JO - G Ital Cardiol (Rome) VL - 14 ID - Perk2013 ER - TY - STD TI - Lüllmann H, Mohr K, Hein L. Pharmakologie und Toxikologie. Georg Thieme Verlag. 2010;207(9):314. ID - ref7 ER - TY - JOUR AU - Patrono, C. PY - 2005 DA - 2005// TI - Low-dose aspirin for the prevention of atherothrombosis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra052717 DO - 10.1056/NEJMra052717 ID - Patrono2005 ER - TY - JOUR AU - Howard, R. L. PY - 2007 DA - 2007// TI - Which drugs cause preventable admissions to hospital? A systematic review JO - Br J Clin Pharmacol VL - 63 UR - https://doi.org/10.1111/j.1365-2125.2006.02698.x DO - 10.1111/j.1365-2125.2006.02698.x ID - Howard2007 ER - TY - JOUR AU - Kongkaew, C. PY - 2013 DA - 2013// TI - Risk factors for hospital admissions associated with adverse drug events JO - Pharmacotherapy VL - 33 UR - https://doi.org/10.1002/phar.1287 DO - 10.1002/phar.1287 ID - Kongkaew2013 ER - TY - JOUR AU - Davies, E. C. PY - 2010 DA - 2010// TI - Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission JO - Br J Clin Pharmacol VL - 70 UR - https://doi.org/10.1111/j.1365-2125.2010.03751.x DO - 10.1111/j.1365-2125.2010.03751.x ID - Davies2010 ER - TY - JOUR AU - Salvi, F. PY - 2012 DA - 2012// TI - Adverse drug events as a cause of hospitalization in older adults JO - Drug Saf VL - 35 UR - https://doi.org/10.1007/BF03319101 DO - 10.1007/BF03319101 ID - Salvi2012 ER - TY - JOUR AU - Fick, D. M. PY - 2003 DA - 2003// TI - Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts JO - Arch Intern Med VL - 163 UR - https://doi.org/10.1001/archinte.163.22.2716 DO - 10.1001/archinte.163.22.2716 ID - Fick2003 ER - TY - JOUR AU - Sorensen, H. T. PY - 2000 DA - 2000// TI - Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin JO - Am J Gastroenterol VL - 95 UR - https://doi.org/10.1111/j.1572-0241.2000.02248.x DO - 10.1111/j.1572-0241.2000.02248.x ID - Sorensen2000 ER - TY - JOUR AU - Franchini, M. PY - 2006 DA - 2006// TI - Hemostasis and aging JO - Crit Rev Oncol Hematol VL - 60 UR - https://doi.org/10.1016/j.critrevonc.2006.06.004 DO - 10.1016/j.critrevonc.2006.06.004 ID - Franchini2006 ER - TY - JOUR AU - Spall, H. G. PY - 2007 DA - 2007// TI - Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.11.1233 DO - 10.1001/jama.297.11.1233 ID - Spall2007 ER - TY - JOUR AU - Boyd, C. M. PY - 2005 DA - 2005// TI - Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JO - JAMA VL - 294 UR - https://doi.org/10.1001/jama.294.6.716 DO - 10.1001/jama.294.6.716 ID - Boyd2005 ER - TY - JOUR AU - Sonnichsen, A. PY - 2016 DA - 2016// TI - Polypharmacy in chronic diseases-reduction of inappropriate medication and adverse drug events in older populations by electronic decision support (PRIMA-eDS): study protocol for a randomized controlled trial JO - Trials VL - 17 UR - https://doi.org/10.1186/s13063-016-1177-8 DO - 10.1186/s13063-016-1177-8 ID - Sonnichsen2016 ER - TY - STD TI - Martinez YM, R.-G.A., Reeves D, Ediriweera de Silva RE, Esmail A, Kunnamo I, Rieckert A, Sommerauer C, Sönnichsen A, A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol. BMC Geriatrics. 2017;17(1). ID - ref19 ER - TY - JOUR AU - Shea, B. J. PY - 2007 DA - 2007// TI - Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews JO - BMC Med Res Methodol VL - 7 UR - https://doi.org/10.1186/1471-2288-7-10 DO - 10.1186/1471-2288-7-10 ID - Shea2007 ER - TY - JOUR AU - Shea, B. J. PY - 2009 DA - 2009// TI - AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews JO - J Clin Epidemiol VL - 62 UR - https://doi.org/10.1016/j.jclinepi.2008.10.009 DO - 10.1016/j.jclinepi.2008.10.009 ID - Shea2009 ER - TY - STD TI - Higgins JPT, G.S., (editors). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from http://handbook-5-1.cochrane.org/. 2011. Last accessed 18 Aug 2017. UR - http://www.cochrane-handbook.org ID - ref22 ER - TY - STD TI - Critical Appraisal Skills Programme. 11 questions to help you make sense of case control study. 2013; Available from: https://hhs.hud.ac.uk/lqsu/Useful/critap/Case%20Control%20Study%20Checklist/CASP-Case-Control-Study-Checklist-31.05.13.pdf. Accessed 18 Aug 2018. UR - https://hhs.hud.ac.uk/lqsu/Useful/critap/Case%20Control%20Study%20Checklist/CASP-Case-Control-Study-Checklist-31.05.13.pdf ID - ref23 ER - TY - STD TI - Critical Appraisal Skills Programme. 12 questions to help you make sense of cohort study. 2013; Available from: https://hhs.hud.ac.uk/lqsu/Useful/critap/Cohort%20Study%20Checklist/CASPCohort-Study-Checklist-31.05.13.pdf. Accessed 18 Aug 2017. UR - https://hhs.hud.ac.uk/lqsu/Useful/critap/Cohort%20Study%20Checklist/CASPCohort-Study-Checklist-31.05.13.pdf ID - ref24 ER - TY - JOUR AU - Guyatt, G. H. PY - 2008 DA - 2008// TI - Going from evidence to recommendations JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39493.646875.AE DO - 10.1136/bmj.39493.646875.AE ID - Guyatt2008 ER - TY - JOUR AU - Guyatt, G. H. PY - 2008 DA - 2008// TI - What is “quality of evidence” and why is it important to clinicians? JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39490.551019.BE DO - 10.1136/bmj.39490.551019.BE ID - Guyatt2008 ER - TY - JOUR AU - Guyatt, G. H. PY - 2008 DA - 2008// TI - GRADE: an emerging consensus on rating quality of evidence and strength of recommendations JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39489.470347.AD DO - 10.1136/bmj.39489.470347.AD ID - Guyatt2008 ER - TY - JOUR AU - Baigent, C. PY - 2009 DA - 2009// TI - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60503-1 DO - 10.1016/S0140-6736(09)60503-1 ID - Baigent2009 ER - TY - JOUR AU - He, J. PY - 1998 DA - 1998// TI - Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.22.1930 DO - 10.1001/jama.280.22.1930 ID - He1998 ER - TY - STD TI - Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007;(3):Cd006186. ID - ref30 ER - TY - JOUR AU - Kjeldsen, S. E. PY - 2000 DA - 2000// TI - Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension optimal treatment JO - J Hypertens VL - 18 UR - https://doi.org/10.1097/00004872-200018050-00017 DO - 10.1097/00004872-200018050-00017 ID - Kjeldsen2000 ER - TY - JOUR AU - Silagy, C. A. PY - 1993 DA - 1993// TI - Adverse effects of low-dose aspirin in a healthy elderly population JO - Clin Pharmacol Ther VL - 54 UR - https://doi.org/10.1038/clpt.1993.115 DO - 10.1038/clpt.1993.115 ID - Silagy1993 ER - TY - JOUR AU - Ogawa, H. PY - 2008 DA - 2008// TI - Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.2008.623 DO - 10.1001/jama.2008.623 ID - Ogawa2008 ER - TY - JOUR PY - 1993 DA - 1993// TI - Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial fibrillation trial) study group JO - Lancet VL - 342 ID - ref34 ER - TY - JOUR AU - Ikeda, Y. PY - 2014 DA - 2014// TI - Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial JO - JAMA VL - 312 UR - https://doi.org/10.1001/jama.2014.15690 DO - 10.1001/jama.2014.15690 ID - Ikeda2014 ER - TY - JOUR AU - Huynh, T. PY - 2001 DA - 2001// TI - Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery JO - Circulation VL - 103 UR - https://doi.org/10.1161/01.CIR.103.25.3069 DO - 10.1161/01.CIR.103.25.3069 ID - Huynh2001 ER - TY - JOUR AU - Taylor, F. C. AU - Cohen, H. AU - Ebrahim, S. PY - 2001 DA - 2001// TI - Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation JO - BMJ VL - 322 UR - https://doi.org/10.1136/bmj.322.7282.321 DO - 10.1136/bmj.322.7282.321 ID - Taylor2001 ER - TY - JOUR AU - Segal, J. B. PY - 2000 DA - 2000// TI - Prevention of thromboembolism in atrial fibrillation: a meta-analysis of trials of anticoagulants and antiplatelet drugs JO - J Gen Intern Med VL - 15 UR - https://doi.org/10.1046/j.1525-1497.2000.04329.x DO - 10.1046/j.1525-1497.2000.04329.x ID - Segal2000 ER - TY - JOUR AU - Hart, R. G. PY - 1999 DA - 1999// TI - Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis JO - Ann Intern Med VL - 131 UR - https://doi.org/10.7326/0003-4819-131-7-199910050-00003 DO - 10.7326/0003-4819-131-7-199910050-00003 ID - Hart1999 ER - TY - JOUR AU - Hart, R. G. AU - Pearce, L. A. AU - Aguilar, M. I. PY - 2007 DA - 2007// TI - Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation JO - Ann Intern Med VL - 146 UR - https://doi.org/10.7326/0003-4819-146-12-200706190-00007 DO - 10.7326/0003-4819-146-12-200706190-00007 ID - Hart2007 ER - TY - JOUR AU - Dogliotti, A. AU - Paolasso, E. AU - Giugliano, R. P. PY - 2014 DA - 2014// TI - Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients JO - Heart VL - 100 UR - https://doi.org/10.1136/heartjnl-2013-304347 DO - 10.1136/heartjnl-2013-304347 ID - Dogliotti2014 ER - TY - JOUR AU - Cooper, N. J. PY - 2006 DA - 2006// TI - Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation JO - Arch Intern Med VL - 166 UR - https://doi.org/10.1001/archinte.166.12.1269 DO - 10.1001/archinte.166.12.1269 ID - Cooper2006 ER - TY - JOUR AU - Andersen, L. V. PY - 2008 DA - 2008// TI - Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis JO - Heart VL - 94 UR - https://doi.org/10.1136/hrt.2007.135657 DO - 10.1136/hrt.2007.135657 ID - Andersen2008 ER - TY - JOUR AU - Assiri, A. PY - 2013 DA - 2013// TI - Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation JO - Clin Ther VL - 35 UR - https://doi.org/10.1016/j.clinthera.2013.05.011 DO - 10.1016/j.clinthera.2013.05.011 ID - Assiri2013 ER - TY - JOUR AU - Lip, G. Y. AU - Edwards, S. J. PY - 2006 DA - 2006// TI - Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis JO - Thromb Res VL - 118 UR - https://doi.org/10.1016/j.thromres.2005.08.007 DO - 10.1016/j.thromres.2005.08.007 ID - Lip2006 ER - TY - JOUR AU - Cameron, C. PY - 2014 DA - 2014// TI - Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-004301 DO - 10.1136/bmjopen-2013-004301 ID - Cameron2014 ER - TY - JOUR AU - Liu, X. PY - 2014 DA - 2014// TI - Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications JO - Int J Clin Pharmacol Ther VL - 52 UR - https://doi.org/10.5414/CP201996 DO - 10.5414/CP201996 ID - Liu2014 ER - TY - JOUR AU - Burton, C. PY - 2006 DA - 2006// TI - The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study JO - Br J Gen Pract VL - 56 ID - Burton2006 ER - TY - JOUR AU - Aguilar, M. I. AU - Hart, R. PY - 2005 DA - 2005// TI - Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks JO - Cochrane Database Syst Rev VL - 19 ID - Aguilar2005 ER - TY - JOUR AU - Uchiyama, S. PY - 2016 DA - 2016// TI - Aspirin for stroke prevention in elderly patients with vascular risk factors: Japanese primary prevention project JO - Stroke VL - 47 UR - https://doi.org/10.1161/STROKEAHA.115.012461 DO - 10.1161/STROKEAHA.115.012461 ID - Uchiyama2016 ER - TY - JOUR AU - Wiviott, S. D. PY - 2007 DA - 2007// TI - Prasugrel versus clopidogrel in patients with acute coronary syndromes JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa0706482 DO - 10.1056/NEJMoa0706482 ID - Wiviott2007 ER - TY - JOUR AU - Zhou, Y. H. PY - 2012 DA - 2012// TI - Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031642 DO - 10.1371/journal.pone.0031642 ID - Zhou2012 ER - TY - JOUR AU - Diener, H. C. PY - 2004 DA - 2004// TI - Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)16721-4 DO - 10.1016/S0140-6736(04)16721-4 ID - Diener2004 ER - TY - JOUR AU - Gandhi, S. PY - 2015 DA - 2015// TI - Comparison of dual-antiplatelet therapy to mono-antiplatelet therapy after Transcatheter aortic valve implantation: systematic review and meta-analysis JO - Can J Cardiol VL - 31 UR - https://doi.org/10.1016/j.cjca.2015.01.014 DO - 10.1016/j.cjca.2015.01.014 ID - Gandhi2015 ER - TY - JOUR AU - Leonardi-Bee, J. PY - 2005 DA - 2005// TI - Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials JO - Stroke VL - 36 UR - https://doi.org/10.1161/01.STR.0000149621.95215.ea DO - 10.1161/01.STR.0000149621.95215.ea ID - Leonardi-Bee2005 ER - TY - JOUR AU - Halkes, P. H. PY - 2008 DA - 2008// TI - Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk JO - J Neurol Neurosurg Psychiatry VL - 79 UR - https://doi.org/10.1136/jnnp.2008.143875 DO - 10.1136/jnnp.2008.143875 ID - Halkes2008 ER - TY - JOUR AU - Warkentin, A. E. PY - 2012 DA - 2012// TI - Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2012.04635.x DO - 10.1111/j.1538-7836.2012.04635.x ID - Warkentin2012 ER - TY - JOUR AU - Britton, M. AU - Helmers, C. AU - Samuelsson, K. PY - 1987 DA - 1987// TI - High-dose acetylsalicylic acid after cerebral infarction. A Swedish cooperative study JO - Stroke VL - 18 UR - https://doi.org/10.1161/01.STR.18.2.325 DO - 10.1161/01.STR.18.2.325 ID - Britton1987 ER - TY - JOUR AU - Sam, C. PY - 2004 DA - 2004// TI - Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham heart study) JO - Am J Cardiol VL - 94 UR - https://doi.org/10.1016/j.amjcard.2004.06.038 DO - 10.1016/j.amjcard.2004.06.038 ID - Sam2004 ER - TY - JOUR AU - Coleman, C. I. PY - 2012 DA - 2012// TI - Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation JO - Int J Clin Pract VL - 66 UR - https://doi.org/10.1111/j.1742-1241.2011.02809.x DO - 10.1111/j.1742-1241.2011.02809.x ID - Coleman2012 ER - TY - JOUR AU - Connolly, B. J. PY - 2013 DA - 2013// TI - Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials JO - J Stroke Cerebrovasc Dis VL - 22 UR - https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.007 DO - 10.1016/j.jstrokecerebrovasdis.2013.01.007 ID - Connolly2013 ER - TY - STD TI - Stroke prevention in atrial fibrillation investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343(8899):687–91. ID - ref62 ER - TY - JOUR AU - Lin, L. PY - 2015 DA - 2015// TI - Clinical and safety outcomes of oral Antithrombotics for stroke prevention in Atrial fibrillation: a systematic review and network meta-analysis JO - J Am Med Dir Assoc VL - 16 UR - https://doi.org/10.1016/j.jamda.2015.09.008 DO - 10.1016/j.jamda.2015.09.008 ID - Lin2015 ER - TY - STD TI - The American geriatrics society 2015 beers criteria update expert panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-46. ID - ref64 ER - TY - STD TI - American geriatrics society 2012 beers criteria update expert panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31. ID - ref65 ER - TY - JOUR AU - O'Mahony, D. PY - 2015 DA - 2015// TI - STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 JO - Age Ageing VL - 44 UR - https://doi.org/10.1093/ageing/afu145 DO - 10.1093/ageing/afu145 ID - O'Mahony2015 ER - TY - JOUR AU - Piepoli, M. F. PY - 2016 DA - 2016// TI - 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR) JO - Atherosclerosis VL - 252 UR - https://doi.org/10.1016/j.atherosclerosis.2016.05.037 DO - 10.1016/j.atherosclerosis.2016.05.037 ID - Piepoli2016 ER - TY - STD TI - ASPREE Investigator Group. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2)555–64. ID - ref68 ER - TY - JOUR AU - Slabaugh, S. L. PY - 2010 DA - 2010// TI - Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy JO - Drugs Aging VL - 27 UR - https://doi.org/10.2165/11584990-000000000-00000 DO - 10.2165/11584990-000000000-00000 ID - Slabaugh2010 ER -